Cargando…

Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real‐World Data

BACKGROUND: Cardiomyopathy is a common cause of atrial fibrillation (AF) and may also present as a complication of AF. However, there is a scarcity of evidence of clinical outcomes for people with cardiomyopathy and concomittant AF. The aim of the present study was therefore to characterize the prev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buckley, Benjamin J. R., Harrison, Stephanie L., Gupta, Dhiraj, Fazio‐Eynullayeva, Elnara, Underhill, Paula, Lip, Gregory Y. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075382/ https://www.ncbi.nlm.nih.gov/pubmed/34779218 http://dx.doi.org/10.1161/JAHA.121.021970

Ejemplares similares

Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19
por: Harrison, Stephanie L., et al.
Publicado: (2020)

Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

Association of Exercise-Based Cardiac Rehabilitation with Progression of Paroxysmal to Sustained Atrial Fibrillation
por: Buckley, Benjamin J. R., et al.
Publicado: (2021)

Exercise‐Based Cardiac Rehabilitation and All‐Cause Mortality Among Patients With Atrial Fibrillation
por: Buckley, Benjamin J. R., et al.
Publicado: (2021)

End-Stage renal disease and 30-day mortality for adults with and without COVID-19
por: Harrison, Stephanie L., et al.
Publicado: (2021)

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
por: Harrison, Stephanie L., et al.
Publicado: (2020)

Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2021)

Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2021)

Frequent premature atrial contractions as a signalling marker of atrial cardiomyopathy, incident atrial fibrillation, and stroke
por: Farinha, José Maria, et al.
Publicado: (2022)

207. Burden of Post-Transplant Neutropenia and Leukopenia among Kidney Transplant Recipients: A Multi-Institutional Real-World Observational Study
por: Raval, Amit D, et al.
Publicado: (2022)

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
por: Ding, Wern Yew, et al.
Publicado: (2020)

The neurocognitive effects of atrial fibrillation: benefits of the ABC pathway
por: Calvert, Peter, et al.
Publicado: (2023)

Atrial fibrillation in obesity: Weighing up the evidence for catheter ablation
por: Javed, Saad, et al.
Publicado: (2020)

Smart Wearables for Cardiac Monitoring—Real-World Use beyond Atrial Fibrillation
por: Duncker, David, et al.
Publicado: (2021)

The impact of frailty on the management of atrial fibrillation
por: Harrison, Stephanie L., et al.
Publicado: (2023)

The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review
por: Stevens, David, et al.
Publicado: (2021)

Catheter ablation for atrial fibrillation in heart failure: untying the Gordian knot
por: Javed, Saad, et al.
Publicado: (2021)

Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis
por: Proietti, Riccardo, et al.
Publicado: (2023)

Evolving Effect of the COVID-19 Pandemic on Cancer-Related Encounters
por: London, Jack W., et al.
Publicado: (2022)

Lipids and atrial fibrillation: New insights into a paradox
por: Sagris, Dimitrios, et al.
Publicado: (2022)

Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis
por: Proietti, Riccardo, et al.
Publicado: (2023)

Relationship between Renal Function, Fibrin Clot Properties and Lipoproteins in Anticoagulated Patients with Atrial Fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

Percutaneous left atrial appendage occlusion following successful treatment of large bi-atrial thrombi in a patient with atrial fibrillation: a case report
por: Ng, Kim Fong, et al.
Publicado: (2023)

Short‐Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity?
por: Ding, Wern Yew, et al.
Publicado: (2019)

Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion
por: Ding, Wern Yew, et al.
Publicado: (2020)

Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial
por: Ding, Wern Yew, et al.
Publicado: (2022)

Atrial Fibrillation Specific Exercise Rehabilitation: Are We There Yet?
por: Buckley, Benjamin J. R., et al.
Publicado: (2022)

Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review
por: Calvert, Peter, et al.
Publicado: (2023)

Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban
por: Lip, Gregory Y. H., et al.
Publicado: (2018)

Atrial Cardiomyopathy and Atrial Fibrillation in Cancer
por: Ren, Mengdi, et al.
Publicado: (2021)

Risk of myocardial infarction and ischemic stroke in individuals with first-diagnosed paroxysmal vs. non-paroxysmal atrial fibrillation under anticoagulation
por: Ntaios, George, et al.
Publicado: (2023)

Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes
por: Yoneda, Zachary T., et al.
Publicado: (2021)

Management of atrial fibrillation
por: Kakar, Puneet, et al.
Publicado: (2007)

Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications
por: Harrison, Stephanie L., et al.
Publicado: (2021)

Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban
por: Tepper, Ping G., et al.
Publicado: (2018)

Survey Study of the Real‐World Outpatient Management of Postoperative Atrial Fibrillation
por: Patel, Nirav V., et al.
Publicado: (2023)

Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project
por: Shahid, Farhan, et al.
Publicado: (2018)

Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry
por: Proietti, Marco, et al.
Publicado: (2021)

Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care
por: Lane, Deirdre A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_15modmfidqhcirp1kv8aetuii8